Revenue (Tables)

12 Months Ended

Dec. 29, 2019

Disaggregation of Revenue [Line Items]

Disaggregation of Revenue [Table Text Block]

In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition. The tables also include a reconciliation of the disaggregated revenue with the reportable segments revenue.

	Reportable Segments
	For the fiscal year ended
	December 29, 2019						December 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total		Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	717,205	$	401,591	$	1,118,796	$	680,117	$	385,005	$	1,065,122
Europe	495,768		291,610		787,378		494,707		283,385		778,092
Asia	533,188		444,311		977,499		518,387		416,395		934,782
	$	1,746,161	$	1,137,512	$	2,883,673	$	1,693,211	$	1,084,785	$	2,777,996
Primary end-markets
Diagnostics	$	—	$	1,137,512	$	1,137,512	$	—	$	1,084,785	$	1,084,785
Life sciences	977,200		—		977,200		934,690		—		934,690
Applied markets	768,961		—		768,961		758,521		—		758,521
	$	1,746,161	$	1,137,512	$	2,883,673	$	1,693,211	$	1,084,785	$	2,777,996
Timing of revenue recognition
Products and services transferred at a point in time	$	1,276,499	$	1,053,974	$	2,330,473	$	1,210,745	$	1,002,213	$	2,212,958
Services transferred over time	469,662		83,538		553,200		482,466		82,572		565,038
	$	1,746,161	$	1,137,512	$	2,883,673	$	1,693,211	$	1,084,785	$	2,777,996